Construction and application of enterprise master patient index based on the national pediatric cancer surveillance platform
10.3760/cma.j.cn111325-20240529-00440
- VernacularTitle:基于国家儿童肿瘤监测平台的患者主索引构建与应用
- Author:
Zhe LI
1
;
Xin XU
;
Xinping LI
;
Xiao ZHANG
;
Guoliang BAI
;
Xiaoyu WANG
;
Yingying LIU
;
Zhuoyu YANG
;
Ming LU
;
Xin NI
Author Information
1. 国家儿童医学中心 首都医科大学附属北京儿童医院国家儿童肿瘤监测中心，北京 100045
- Publication Type:Journal Article
- Keywords:
Pediatric cancer;
Enterprise master patient index;
Unique identification code;
Index system;
Recognition logic
- From:
Chinese Journal of Hospital Administration
2024;40(12):923-927
- CountryChina
- Language:Chinese
-
Abstract:
The enterprise master patient index is an important tool for identifying the diagnosis and treatment records of the same patient in heterogeneous medical data from multiple sources. From June to December 2021, the National Children′s Cancer Monitoring Center screened and determined the enterprise master patient index index system and its recognition logic by literature analysis and expert consultation. Based on the National Children′s Cancer surveillance Platform (hereinafter referred to as the surveillance platform), a corresponding intelligent recognition algorithm system was developed. After multiple rounds of real data verification and adjustment, a enterprise master patient index suitable for multi-source heterogeneous medical data was constructed. From January 2022 to March 2024, the intelligent recognition algorithm system had completed the recognition of 2.46 million pediatric tumor case report cards, established 0.33 million primary indexes and their unique identification codes for malignant tumor patients, and improved the data management and application efficiency of the surveillance platform. The enterprise master patient index based on surveillance platforms had played an important role in the registration and follow-up of pediatric cancer cases and related medical research, which could provide references for the construction of master indexes on other medical big data platforms in China.
